2021 AHA科学声明:急性缺血性卒中患者的护理(院前和急性期护理)

2021-03-11 美国心脏协会 Stroke .2021 Mar 11;

2021年3月,美国心脏协会(AHA)发布了急性缺血性卒中患者的护理(院前和急性期护理)声明。本文是对2009年急性缺血性卒中患者综合护理及多学科护理声明的更新。目的是为急性缺血性卒中患者的院前以及急

中文标题:

2021 AHA科学声明:急性缺血性卒中患者的护理(院前和急性期护理)

英文标题:

Care of the Patient With Acute Ischemic Stroke (Prehospital and Acute Phase of Care): Update to the 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart Association

发布机构:

美国心脏协会

发布日期:

2021-03-11

简要介绍:

2021年3月,美国心脏协会(AHA)发布了急性缺血性卒中患者的护理(院前和急性期护理)声明。本文是对2009年急性缺血性卒中患者综合护理及多学科护理声明的更新。目的是为急性缺血性卒中患者的院前以及急性期护理提供指导。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 AHA科学声明:急性缺血性卒中患者的护理(院前和急性期护理).pdf)] GetToolGuiderByIdResponse(projectId=1, id=bdc6d1c0020e65c4, title=2021 AHA科学声明:急性缺血性卒中患者的护理(院前和急性期护理), enTitle=Care of the Patient With Acute Ischemic Stroke (Prehospital and Acute Phase of Care): Update to the 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart Association, guiderFrom=Stroke .2021 Mar 11;, authorId=0, author=, summary=2021年3月,美国心脏协会(AHA)发布了急性缺血性卒中患者的护理(院前和急性期护理)声明。本文是对2009年急性缺血性卒中患者综合护理及多学科护理声明的更新。目的是为急性缺血性卒中患者的院前以及急, cover=https://img.medsci.cn/2021330/1617115574039_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Thu Mar 11 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年3月,美国心脏协会(AHA)发布了急性缺血性卒中患者的护理(院前和急性期护理)声明。本文是对2009年急性缺血性卒中患者综合护理及多学科护理声明的更新。目的是为急性缺血性卒中患者的院前以及急性期护理提供指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=4420, tagName=急性缺血性卒中)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4420, guiderKeyword=急性缺血性卒中, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14905, appHits=345, showAppHits=0, pcHits=681, showPcHits=14560, likes=3, shares=25, comments=23, approvalStatus=1, publishedTime=Tue Mar 30 23:50:47 CST 2021, publishedTimeString=2021-03-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Mar 30 22:46:32 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 01:11:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHA科学声明:急性缺血性卒中患者的护理(院前和急性期护理).pdf)])
2021 AHA科学声明:急性缺血性卒中患者的护理(院前和急性期护理).pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1071295, encodeId=be9810e1295cb, content=值得 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:26 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071294, encodeId=68a510e12946f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:10 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071292, encodeId=11f610e129275, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:44:31 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012962, encodeId=9cca1012962d5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541e5589173, createdName=ms2000000232058198, createdTime=Mon Aug 30 19:37:36 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006997, encodeId=e0fc100699efe, content=非常好!学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/13/6b2602171cf95896be72b9b4bc8f16f4.jpg, createdBy=c0265249663, createdName=147db139m66暂无昵称, createdTime=Wed Aug 11 17:37:13 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-11-18 liuyingying35

    值得

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1071295, encodeId=be9810e1295cb, content=值得 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:26 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071294, encodeId=68a510e12946f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:10 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071292, encodeId=11f610e129275, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:44:31 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012962, encodeId=9cca1012962d5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541e5589173, createdName=ms2000000232058198, createdTime=Mon Aug 30 19:37:36 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006997, encodeId=e0fc100699efe, content=非常好!学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/13/6b2602171cf95896be72b9b4bc8f16f4.jpg, createdBy=c0265249663, createdName=147db139m66暂无昵称, createdTime=Wed Aug 11 17:37:13 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-11-18 liuyingying35

    值得学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1071295, encodeId=be9810e1295cb, content=值得 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:26 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071294, encodeId=68a510e12946f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:10 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071292, encodeId=11f610e129275, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:44:31 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012962, encodeId=9cca1012962d5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541e5589173, createdName=ms2000000232058198, createdTime=Mon Aug 30 19:37:36 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006997, encodeId=e0fc100699efe, content=非常好!学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/13/6b2602171cf95896be72b9b4bc8f16f4.jpg, createdBy=c0265249663, createdName=147db139m66暂无昵称, createdTime=Wed Aug 11 17:37:13 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-11-18 liuyingying35

    值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1071295, encodeId=be9810e1295cb, content=值得 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:26 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071294, encodeId=68a510e12946f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:10 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071292, encodeId=11f610e129275, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:44:31 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012962, encodeId=9cca1012962d5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541e5589173, createdName=ms2000000232058198, createdTime=Mon Aug 30 19:37:36 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006997, encodeId=e0fc100699efe, content=非常好!学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/13/6b2602171cf95896be72b9b4bc8f16f4.jpg, createdBy=c0265249663, createdName=147db139m66暂无昵称, createdTime=Wed Aug 11 17:37:13 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-30 ms2000000232058198

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1071295, encodeId=be9810e1295cb, content=值得 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:26 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071294, encodeId=68a510e12946f, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:49:10 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071292, encodeId=11f610e129275, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/d028dd72803b466fbec4fbb95fb69ab8/36dc5ab269ac424d983ff54da9dc4e15.jpg, createdBy=37881573320, createdName=liuyingying35, createdTime=Thu Nov 18 08:44:31 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012962, encodeId=9cca1012962d5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541e5589173, createdName=ms2000000232058198, createdTime=Mon Aug 30 19:37:36 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006997, encodeId=e0fc100699efe, content=非常好!学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/13/6b2602171cf95896be72b9b4bc8f16f4.jpg, createdBy=c0265249663, createdName=147db139m66暂无昵称, createdTime=Wed Aug 11 17:37:13 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-11 147db139m66暂无昵称

    非常好!学习了

    0